Harmonizing TREC Thresholds in Newborn Screening for SCID: Insights From Russian Validation Cohort

IF 2.9 4区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY
Andrey Marakhonov, Ekaterina Kalinina, Sergey Larin, Maryam Khadzhieva, Ekaterina Dudina, Anna Mukhina, Yulia Rodina, Irina Efimova, Natalya Balinova, Irina Sermyagina, Olga Shchagina, Rena Zinchenko, Sergey Voronin, Anna Shcherbina, Sergey Kutsev
{"title":"Harmonizing TREC Thresholds in Newborn Screening for SCID: Insights From Russian Validation Cohort","authors":"Andrey Marakhonov,&nbsp;Ekaterina Kalinina,&nbsp;Sergey Larin,&nbsp;Maryam Khadzhieva,&nbsp;Ekaterina Dudina,&nbsp;Anna Mukhina,&nbsp;Yulia Rodina,&nbsp;Irina Efimova,&nbsp;Natalya Balinova,&nbsp;Irina Sermyagina,&nbsp;Olga Shchagina,&nbsp;Rena Zinchenko,&nbsp;Sergey Voronin,&nbsp;Anna Shcherbina,&nbsp;Sergey Kutsev","doi":"10.1002/jcla.70078","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Newborn screening (NBS) for severe combined immunodeficiency (SCID) relies on the measurement of T-cell receptor excision circle (TREC) for early diagnosis and intervention. However, considerable variation in TREC cutoff values across countries and testing platforms poses challenges for standardization and optimal screening performance. This study aimed to refine the TREC cutoff values in a large Russian pilot NBS cohort comprising 202,908 newborns, with a primary focus on improving SCID detection sensitivity.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>A retrospective analysis of 202,908 newborns from a pilot NBS project assessed TREC and KREC levels. Confirmed PID diagnoses were compared with TREC measurements in a group of 66 false-positive cases. The optimal TREC cutoff was established using ROC analysis, with validation across patients with SCID, 22q11.2 deletion syndrome (22q11.2DS), and syndromic forms of PID from an extended validation cohort of PID patients from the Dmitry Rogachev National Medical Research Center.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Receiver operating characteristic (ROC) analysis based on true-positive cases identified an optimal TREC cutoff of 150 copies/10<sup>5</sup> cells. Values between 150–200 copies/10<sup>5</sup> cells were found to identify high-risk newborns who require closer monitoring. This threshold was validated in an independent cohort, reducing missed SCID cases while improving the detection of 22q11.2 deletion syndrome and other syndromic primary immunodeficiencies (PIDs). Notably, elevated TREC levels in some SCID patients reflected “leaky” SCID phenotypes, which nonetheless required curative intervention. Additionally, syndromic PIDs and cases of transient idiopathic lymphopenia (TIL) were also more accurately identified, enabling timely clinical management.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>These findings emphasize the need for broader evaluation of TREC cutoff values across diverse assay systems to improve the effectiveness, comparability, and global harmonization of NBS programs.</p>\n </section>\n </div>","PeriodicalId":15509,"journal":{"name":"Journal of Clinical Laboratory Analysis","volume":"39 16","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jcla.70078","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Laboratory Analysis","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jcla.70078","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Newborn screening (NBS) for severe combined immunodeficiency (SCID) relies on the measurement of T-cell receptor excision circle (TREC) for early diagnosis and intervention. However, considerable variation in TREC cutoff values across countries and testing platforms poses challenges for standardization and optimal screening performance. This study aimed to refine the TREC cutoff values in a large Russian pilot NBS cohort comprising 202,908 newborns, with a primary focus on improving SCID detection sensitivity.

Methods

A retrospective analysis of 202,908 newborns from a pilot NBS project assessed TREC and KREC levels. Confirmed PID diagnoses were compared with TREC measurements in a group of 66 false-positive cases. The optimal TREC cutoff was established using ROC analysis, with validation across patients with SCID, 22q11.2 deletion syndrome (22q11.2DS), and syndromic forms of PID from an extended validation cohort of PID patients from the Dmitry Rogachev National Medical Research Center.

Results

Receiver operating characteristic (ROC) analysis based on true-positive cases identified an optimal TREC cutoff of 150 copies/105 cells. Values between 150–200 copies/105 cells were found to identify high-risk newborns who require closer monitoring. This threshold was validated in an independent cohort, reducing missed SCID cases while improving the detection of 22q11.2 deletion syndrome and other syndromic primary immunodeficiencies (PIDs). Notably, elevated TREC levels in some SCID patients reflected “leaky” SCID phenotypes, which nonetheless required curative intervention. Additionally, syndromic PIDs and cases of transient idiopathic lymphopenia (TIL) were also more accurately identified, enabling timely clinical management.

Conclusion

These findings emphasize the need for broader evaluation of TREC cutoff values across diverse assay systems to improve the effectiveness, comparability, and global harmonization of NBS programs.

Abstract Image

协调新生儿SCID筛查中的TREC阈值:来自俄罗斯验证队列的见解。
背景:新生儿严重联合免疫缺陷(SCID)筛查(NBS)依赖于t细胞受体切除圈(TREC)的测量进行早期诊断和干预。然而,不同国家和检测平台之间TREC截止值的巨大差异为标准化和最佳筛查性能带来了挑战。本研究旨在完善俄罗斯大型试点NBS队列(包括202908名新生儿)的TREC截止值,主要关注提高SCID检测灵敏度。方法:回顾性分析来自NBS试点项目的202,908名新生儿的TREC和KREC水平。将66例假阳性病例的确诊PID诊断与TREC测量结果进行比较。采用ROC分析确定最佳TREC截止点,并对SCID、22q11.2缺失综合征(22q11.2 ds)患者和来自Dmitry Rogachev国家医学研究中心的PID患者扩展验证队列的PID综合征形式进行验证。结果:基于真阳性病例的受试者工作特征(ROC)分析确定了最佳TREC截止值为150拷贝/105个细胞。150-200拷贝/105个细胞之间的数值可以确定需要密切监测的高危新生儿。该阈值在一个独立队列中得到验证,减少了SCID漏诊病例,同时提高了22q11.2缺失综合征和其他综合征性原发性免疫缺陷(pid)的检测。值得注意的是,一些SCID患者TREC水平升高反映了SCID“渗漏”表型,尽管如此,这仍需要治疗性干预。此外,综合征性PIDs和一过性特发性淋巴细胞减少症(TIL)病例也能更准确地识别,从而能够及时进行临床治疗。结论:这些发现强调需要对不同检测系统的TREC截止值进行更广泛的评估,以提高NBS项目的有效性、可比性和全球一致性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical Laboratory Analysis
Journal of Clinical Laboratory Analysis 医学-医学实验技术
CiteScore
5.60
自引率
7.40%
发文量
584
审稿时长
6-12 weeks
期刊介绍: Journal of Clinical Laboratory Analysis publishes original articles on newly developing modes of technology and laboratory assays, with emphasis on their application in current and future clinical laboratory testing. This includes reports from the following fields: immunochemistry and toxicology, hematology and hematopathology, immunopathology, molecular diagnostics, microbiology, genetic testing, immunohematology, and clinical chemistry.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信